. Typical patterns of glycosylation of a1-acid glycoprotein demonstrated by immunoaffinity electrophoresis in sera from (A) a patient with nontuberculous pneumonia (S. pneumoniae), (B) a healthy control, and (C) a patient with tuberculosis of the lung.
Each peak represents a single subpopulation: fraction 1, nonreactive;fractions 2 and 3, weakly reactive; fraction 4, strongly reactive with Con A.
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The differential diagnosis between tuberculosis and other bacterial lung infections may present difficulties in certain cases. New markers of inflammation may serve as additional tools in the differential diagnosis of bacterial lung infections.
The acute-phase reactant a1-acid glycoprotein (AGP; orosomucoid) reveals microheterogeneity in the proportions of bi-, tri-, or tetraantennary oligosaccharides bound to its glycosylation sites (1), which can be revealed by agarose-based immunoaffinity electrophoresis with free concanavalin A (Con A) as ligand (2).
In this preliminary study, changes of glycosylation have been studied in 21 patients (15 men, 6 women), ages 19-63 years (median 37) with active tuberculosis of the lung. In 13 patients, the primary diagnosis was based on the finding of acid-fast bacteria on smear; the other 8 were diagnosed from the clinical picture and the typical roentgenograms.
All diagnoses were confirmed by positive cultures of Mycobacterium tuberculosis.
We also studied sera from 27 patients (16 men, 11 women), ages 19-90 years (median 72), with nontuberculous bacterial pneumonia (NTP) diagnosed clinically (fever, cough, expectoration), radiologically (new infiltrate), by sputum analysis (>25 leukocytes per high-power field), and in most cases by the cultural evidence of a predominant microorganism. The causative organisms were Streptococcus pneumoniae (n = 13), Haemophilus influenzae (n = 6), and Group C streptococcus (n = 1). In three patients, gram-negative rods without results in culture (n = 3) were found, and four patients were diagnosed as having aspiration pneumonia on the basis of typical clinical picture, sputum leukocytosis, roentgenograin, and outcome of therapy. 
AGP-Con
A reactivity coefficient (AGP-RC), defined as the ratio of the area below the peaks of all the Con A-reactive subpopulations (peaks 2+3 + 4) with that of the peak of the Con A-nonreactive fraction (peak 1) (3). AGP was measured by rocket immunoelectrophoresis.
Resultswere expressed as mean ± SD; for statistical analyses, we used the Mann-Whitney test. Compared with those in healthy controls (0.83 ± 0.14 g/L), the serum concentrations of AGP were significantly increased in both tuberculosis (1.41 ± 0.66 g/L; P <0.0005) and NTP (1.48 ± 0.39 g/L; P <0.001). Because concentrations did not differ between the two inflammatory diseases (P = 0.28, not significant), their determination seems to be without any practical importance for differential diagnosis of these diseases. When analyzed by the Laurell method, concentrations of AGP may be slightly underestimated because of a possible decreased sialylation of AGP in tuberculosis; this situation, however, would not alter the interpretation of the results.
Immunoaffinity electrophoresis separated AGP into two to four different microheterogeneous forms, each corresponding to single peaks of different reactivities toward Con A (Fig. 1) . In contrast to its concentration in serum, the degree of glycosylation of AGP, expressed as AGP-RC values, significantly differed in patients with tuberculosis (0.95 ± 0.25) and those with NIP (2.26 ± 0.80, P <0.0001). In this study, an appropriate AGP-RC cutoff of 1.4 differentiated between tuberculosis and NTP with a sensitivity of 86% and a specificity of 93%. Therefore, this novel marker may be a useful additional tool in the differential diagnosis of bacterial lung diseases. For these comparisons, we have not corrected the lectin reactivities for serum concentrations of AGP, which may turn out to be important in estimations between conditions exhibiting different serum concentrations. In this preliminary study, however, AGP concentrations in tuberculosis and other bacterial lung infections did not significantly differ; thus, differences of glycosylation can directly be compared. Con A reactivity expressed in the healthy controls was 1.21 ± 0.14, which is consistent with earlier studies (3, 4). The pattern of glycosylation of AGP in tuberculosis was similar to that described earlier in rheumatoid arthritis, ankylosing spondylitis, Crohn disease, or osteomyelitis, whereas the changes in NTP corresponded to those observed in sepsis (1, 3, 4) . Neither the mechanism nor the biological significance of these glycosylation changes is understood. In all study groups investigated, AGP-RC did not correlate with concentrations of AGP, confirming the independency between glycosylation and serum contents of this acute- 
Upid and Thyroid Changes After

Partial Thyroidectomy
Guidelines for L-Thyroxine Therapy?
To the Editor:
Subclinical hypothyroidism, defined as normal concentrations of thyroxine (T4) with increased concentrations of thyrotropin (TSH), could, like overt hypothyroidism (low free T4), be a risk factor of atherosclerosis or coronary heart disease, given its potential for association with an atheroge"ic proffle (increased low-density lipoproteins) (1). Through decreasing the thyroid parenchyma, partial thyroidectomy could induce subclinical or overt hypothyroidism.
The aim of this study was: (a) to confirm that partial thyroidectomy causes changes in blood lipid and lipoprotein concentrations, and (b) to determine whether T4 treatment was necessary after such surgery.
Forty-two patients who underwent partial thyroidectomy were included in this study. We excluded patients with preoperative hypothyroidism, hepatic cholestasis, kidney failure, or diabetes meffitus, and those taking lipid-reducing drugs or oral contraceptives. The patients, 33 women and 9 men [mean age = 45 ± 3 years (range = 19 to 65)] were followed up for 9 months after their surgery. We measured lipids, free T4, free triiodothyronine (T3), and TSH preoperatively and 3 and 9 months postoperatively. Three months after surgery, the subjects were randomized into two treatment groups: those receiving placebo (n = 20) and those taking T4, 1 pg/kg body wt. daily (n = 22). All the procedures followed were in accordance with the Helsinki Declaration of 1975, as revised in 1983.
Total cholesterol (TC) and triglycerides (TG) were measured in serum with the CHOD-PAP#{174} and Free T4 was lower after the operation than before (11.3 ± 0.3 vs 12.6 ± 0.3 ng/L, P <0.001), whereas TSH was higher (1.9 ± 0.2 vs 0.9 ± 0.1 mIU/L; P <0.001). Three months after surgery, no patient was in overt hypothyroidism (increased TSH and T4 <10 ng/L), but five patients were in subclinical hypothyroidism: Two had abnormally increased TSH (6.7 and 7.5 mIU/L), and three exhibited exaggerated TSH response to thyroliberin (TRH) (TSH at 20 mm exceeded 20 mIU/L: 21.9, 23.8, 25.7 mIU/L). One of these five patients (TSH = 6.7 mIU/L) was in the T4-treated group, four were in the placebo group. Nine months after surgery, the T4-treated patient had normal TSH and TSH response, two of the four placebo-treated patients had normal TSH and TSH response, and two had normal TSH but still an exaggerated TSH response (TSH at 20 min = 21 and 29.2 mIU/L).
No difference in serum concentrations was found between pre-and postoperative times for TC, TG, HDL-c, LDL-c, LDL-c/HDL-c, HDL-cl TC, apo A-I, and apo B. Lipid-related variables did not differ with treatment 9 months after surgery, excepted for improved HDL-c in the T4-treated group (+8% vs -2%, P <0.05). Nine months after surgery, the two patients with the highest TSH response to TRH had higher concentrations of atherogenic lipids (Table 1) , and TSH was significantly (P <0.05) correlated with TC (r = 0.55), apo B (r = 0.40), and LDL-c (r = 0.59).
The Framingham study (3) has shown the poor prognosis for coronary mortality evidenced by increased atherogenic lipids. Thyroid hormones increase lipoprotein lipase activity 
